The 18th edition of the International Congress on Targeted Anticancer Therapies (TAT) will take place in Paris, 2-4 March 2020.
ESMO-MORA: The TAT 2020 programme has been accredited with 24 cat.1 ESMO-MORA points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details.
The congress webcasts will include all the sessions of the official programme, where speaker permission is granted, and will be available on this website and on OncologyPRO for ESMO members.